LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro

References

• Economopoulou P, Kotsantis I, Psyrri A. The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches. ESMO Open. 2016;1(6):e000122. doi:10.1136/esmoopen-2016-00012228848660
   PubMed Web of Science ®Google Scholar
• Braakhuis BJ, Leemans CR, Visser O. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol. 2014;50(7):670–675. doi:10.1016/j.oraloncology.2014.03.00824735546
   PubMed Web of Science ®Google Scholar
• McGuire S. World cancer report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO press, 2015. Adv Nutr. 2016;7(2):418–419. doi:10.3945/an.116.01221126980827
   PubMed Web of Science ®Google Scholar
• Andre K, Schraub S, Mercier M, Bontemps P. Role of alcohol and tobacco in the aetiology of head and neck cancer: a case-control study in the Doubs region of France. Eur J Cancer B Oral Oncol. 1995;31B(5):301–309.8704646
   PubMed Web of Science ®Google Scholar
• Kiprian D, Czarkowska-Paczek B, Wyczalkowska-Tomasik A, Paczek L. Human cytomegalovirus and Epstein-Barr virus infections increase the risk of death in patients with head and neck cancers receiving radiotherapy or radiochemotherapy. Medicine. 2018;97(51):e13777. doi:10.1097/MD.000000000001377730572533
   PubMed Web of Science ®Google Scholar
• Moon JJ, Lu A, Moon C. Role of genomic instability in human carcinogenesis. Exp Biol Med. 2019;1535370219826031. doi:10.1177/1535370219826031
   Web of Science ®Google Scholar
• Li S, Zhang S, Chen J. c-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma. Cancer Gene Ther. 2019. doi:10.1038/s41417-018-0072-8
   Web of Science ®Google Scholar
• Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res. 1994;54(13):3580–3587.8012985
   PubMed Web of Science ®Google Scholar
• Arunsingh M, Vaidyanathan S, Dyker KE, Sen M, Scarsbrook AF, Prestwich RJD. Accuracy of response assessment positron emission tomography-computed tomography following definitive radiotherapy without chemotherapy for head and neck squamous cell carcinoma. Clin Oncol. 2018. doi:10.1016/j.clon.2018.11.036
   Google Scholar
• Elicin O, Cihoric N, Vlaskou Badra E, Ozsahin M. Emerging patient-specific treatment modalities in head and neck cancer - a systematic review. Expert Opin Investig Drugs. 2019;28:365–376. doi:10.1080/13543784.2019.1582642
   PubMed Web of Science ®Google Scholar
• Huan J, Xing L, Lin Q, Xui H, Qin X. Long noncoding RNA CRNDE activates Wnt/beta-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer. Am J Transl Res. 2017;9(4):1977–1989.28469804
   PubMed Web of Science ®Google Scholar
• Chen T, Xue H, Lin R, Huang Z. MiR-34c and PlncRNA1 mediated the function of intestinal epithelial barrier by regulating tight junction proteins in inflammatory bowel disease. Biochem Biophys Res Commun. 2017;486(1):6–13. doi:10.1016/j.bbrc.2017.01.11528153728
   PubMed Web of Science ®Google Scholar
• Yang XJ, Huang CQ, Peng CW, Hou JX, Liu JY. Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression. Gene. 2016;592(1):172–178. doi:10.1016/j.gene.2016.08.00227496341
   PubMed Web of Science ®Google Scholar
• Xue D, Lu H, Xu HY, Zhou CX, He XZ. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. J Cell Mol Med. 2018;22(6):3223–3237. doi:10.1111/jcmm.1360429633510
   PubMed Web of Science ®Google Scholar
• Tsai KW, Lo YH, Liu H, et al. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer. Mol Cancer. 2018;17(1):72. doi:10.1186/s12943-018-0821-129523145
   PubMedGoogle Scholar
• Chen L, Dzakah EE, Shan G. Targetable long non-coding RNAs in cancer treatments. Cancer Lett. 2018;418:119–124. doi:10.1016/j.canlet.2018.01.04229341880
   PubMed Web of Science ®Google Scholar
• Liu XX, Xiong HP, Huang JS, Qi K, Xu JJ. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma. Clin Exp Pharmacol Physiol. 2017;44(8):895–902. doi:10.1111/1440-1681.1278028477368
   PubMed Web of Science ®Google Scholar
• Wu ZJ, Li Y, Wu YZ, et al. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-beta signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(4):706–714.28272713
   PubMed Web of Science ®Google Scholar
• Wang L, Bu P, Ai Y, et al. A long non-coding RNA targets microRNA miR-34a to regulate colon cancer stem cell asymmetric division. eLife. 2016;5. doi:10.7554/eLife.14620
   Web of Science ®Google Scholar
• Seitz AK, Christensen LL, Christensen E, et al. Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer. Sci Rep. 2017;7(1):395. doi:10.1038/s41598-017-00327-028341852
   PubMedGoogle Scholar
• Guo E, Liang C, He X, et al. Long noncoding RNA LINC00958 accelerates gliomagenesis through regulating miR-203/CDK2. DNA Cell Biol. 2018;37(5):465–472. doi:10.1089/dna.2018.416329570358
   PubMed Web of Science ®Google Scholar
• Chen S, Chen JZ, Zhang JQ, et al. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8. Cancer Lett. 2019;446:49–61. doi:10.1016/j.canlet.2018.12.01730639194
   PubMed Web of Science ®Google Scholar
• Wang W, Song ZJ, Wang Y, Zhong WF, Kang P, Yang Y. Elevated long non-coding RNA LINC00958 was associated with metastasis and unfavorable prognosis in gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23(2):598–603. doi:10.26355/eurrev_201901_1687230720167
   PubMed Web of Science ®Google Scholar
• Liu Z, Huang S, Cao Y, et al. YAP1 inhibits circRNA-000425 expression and thus promotes oncogenic activities of miR-17 and miR-106. Biochem Biophys Res Commun. 2018;503(4):2370–2375. doi:10.1016/j.bbrc.2018.06.16330017188
   PubMed Web of Science ®Google Scholar
• Huang S, Zhu L, Cao Y, et al. Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients. Oncotarget. 2017;8(46):80303–80314. doi:10.18632/oncotarget.1793229113304
   PubMedGoogle Scholar
• Yang X, Ye H, He M, et al. LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma. Biochem Biophys Res Commun. 2018;498(1):207–213. doi:10.1016/j.bbrc.2018.02.21129501744
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang B, Zhang M, et al. lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer. Cancer Cell. 2018;33(4):706–20 e9. doi:10.1016/j.ccell.2018.03.00629622465
   PubMed Web of Science ®Google Scholar
• Iaccarino I. lncRNAs and MYC: an intricate relationship. Int J Mol Sci. 2017;18(7):1497. doi:10.3390/ijms18071497
   PubMed Web of Science ®Google Scholar
• Liu Z, Yao Y, Huang S, et al. LINC00662 promotes gastric cancer cell growth by modulating the Hippo-YAP1 pathway. Biochem Biophys Res Commun. 2018;505(3):843–849. doi:10.1016/j.bbrc.2018.09.19130297104
   PubMed Web of Science ®Google Scholar
• Si X, Zang R, Zhang E, et al. LncRNA H19 confers chemoresistance in ERalpha-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK. Oncotarget. 2016;7(49):81452–81462. doi:10.18632/oncotarget.1326327845892
   PubMedGoogle Scholar
• He W, Zhong G, Jiang N, et al. Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis. J Clin Invest. 2018;128(2):861–875. doi:10.1172/JCI9621829355840
   PubMed Web of Science ®Google Scholar
• Gabay M, Li Y, Felsher DW. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med. 2014;4(6):a014241. doi:10.1101/cshperspect.a01424124890832
   PubMed Web of Science ®Google Scholar
• Li F, Li H, Zhang L, et al. X chromosome-linked long noncoding RNA lnc-XLEC1 regulates c-Myc-dependent cell growth by collaborating with MBP-1 in endometrial cancer. Int J Cancer. 2019. doi:10.1002/ijc.32166
   Web of Science ®Google Scholar
• Xiao X, Gu Y, Wang G, Chen S. c-Myc, RMRP, and miR-34a-5p form a positive-feedback loop to regulate cell proliferation and apoptosis in multiple myeloma. Int J Biol Macromol. 2019;122:526–537. doi:10.1016/j.ijbiomac.2018.10.20730389523
   PubMed Web of Science ®Google Scholar
• Zeng C, Liu S, Lu S, et al. The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells. Mol Cancer. 2018;17(1):130. doi:10.1186/s12943-018-0884-z30153828
   PubMedGoogle Scholar
• Yu Q, Zhou X, Xia Q, et al. Long non-coding RNA CCAT1 that can be activated by c-Myc promotes pancreatic cancer cell proliferation and migration. Am J Transl Res. 2016;8(12):5444–5454.28078015
   PubMed Web of Science ®Google Scholar
• Xiang S, Gu H, Jin L, Thorne RF, Zhang XD, Wu M. LncRNA IDH1-AS1 links the functions of c-Myc and HIF1alpha via IDH1 to regulate the Warburg effect. Proc Natl Acad Sci U S A. 2018;115(7):E1465–E1474. doi:10.1073/pnas.171125711529378948
   PubMed Web of Science ®Google Scholar
• Moskalev EA, Schubert M, Hoheisel JD. RNA-directed epigenomic reprogramming: an emerging principle of a more targeted cancer therapy? Genes Chromosomes Cancer. 2012;51(2):105–110. doi:10.1002/gcc.2094322045689
   PubMed Web of Science ®Google Scholar
• Doose G, Haake A, Bernhart SH, et al. MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 2015;112(38):E5261–E5270. doi:10.1073/pnas.150575311226351698
   PubMed Web of Science ®Google Scholar
• Hung CL, Wang LY, Yu YL, et al. A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A. 2014;111(52):18697–18702. doi:10.1073/pnas.141566911225512540
   PubMed Web of Science ®Google Scholar
• Ganesan S. MYC, PARP1, and chemoresistance: BIN there, done that? Sci Signal. 2011;4(166):pe15. doi:10.1126/scisignal.200194621447796
   PubMed Web of Science ®Google Scholar
• Wang WJ, Wu SP, Liu JB, et al. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells. Cancer Res. 2013;73(3):1219–1231. doi:10.1158/0008-5472.CAN-12-140823269272
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou L, Nan Z, et al. Knockdown of cMyc activates Fas-mediated apoptosis and sensitizes A549 cells to radiation. Oncol Rep. 2017;38(4):2471–2479. doi:10.3892/or.2017.589728849062
   PubMed Web of Science ®Google Scholar